Factor Model (net +1.1)
Factor Model
net +1.1
Est. Revisions
+0.5
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+0.0
Narrative Gap
+0.0
Analysis pending — waiting for first signal cycle.
Evidence
16d ago
Insider buy by MILLIGAN SANDRA (GOSS): $50,016
16d ago
Insider buy by GIRAUDO BRYAN M. (GOSS): $59,110
16d ago
Insider buy by SMITH ROBERT PAUL JR (GOSS): $15,050
30d ago
Why Bullish Analysts Still See Major Upside in Gossamer Bio (GOSS) After PROSERA Setback
yahoo-finance
39d ago
Analysts Revise Forecasts for Gossamer Bio (GOSS) Amid Uncertain Regulatory Environment
yahoo-finance
Fundamentals & Data ▾
Gossamer Bio, Inc.
Healthcare · Biotechnology
Mkt Cap
$88M
Beta
2.16
52w Range
$0.32 - $3.87
Short Interest
37.5M 16.97%
Days to Cover
2.7 +8%
Technicals
downtrend
from 52w Hi
-23.3%
1w return
-8.5%
Insiders
buying
3B / 1S
EPS Estimate
$-0.17
+9.2% 30d
1up / 1dn
Est. Dispersion
118%
7 analysts
Analyst Target
$4
$0 - $15
Options P/C
0.65
Insider Cluster
strong buy
3B / 1S (officer)
Fund Convergence
strong
Two Sigma, Citadel, Renaissance, D.E. Shaw
Financials
Revenue
$14M +47% YoY
FCF
$-48M
Op Margin
-334%
Momentum:
decelerating
Top Holders
Two Sigma
$8M
Citadel
$5M
Renaissance
$2M
D.E. Shaw
$2M
Recent Filings & Data
insider trade
16
net buying
· $1,576 sold
· $124,176 bought
7 insiders · 16 transactions (30d)
Recent transactions
HASNAIN FAHEEM · award
GIRAUDO BRYAN M. · award
PETERSON CARYN · award
ARANDA RICHARD · award
CHRISTIAN WAAGE · award
SMITH ROBERT PAUL JR · award
HASNAIN FAHEEM · award
GIRAUDO BRYAN M. · award
PETERSON CARYN · award
ARANDA RICHARD · award
CHRISTIAN WAAGE · award
SMITH ROBERT PAUL JR · award
MILLIGAN SANDRA · buy · $50,016
ARANDA RICHARD · sell · $1,576
GIRAUDO BRYAN M. · buy · $59,110
SMITH ROBERT PAUL JR · buy · $15,050
6 signals · latest 16d ago
Get alerted when GOSS changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.